In a move aimed at securing a place in the rapidly evolving food technology scene, the agricultural giant Monsanto has invested $US125 million in a gene-editing startup called Pairwise.
RNZ’s collection of interviews about CRISPR
New Scientist’s articles on genetic modification particularly CRISPR
This resource will help you to: - understand the science behind gene transfer - think about the implications of our newly-acquired ability to move genes from one living thing to another - and grapple with the issues involved in producing medical treatments from genetic engineering.
Gene editing, or genome editing, is a new type of genetic engineering that is revolutionizing human medicine and agriculture. These techniques give scientists the ability to more precisely modify the genome of almost any organism.